 | • レポートコード：MRC22NVL19416 • 出版社/出版日：LP Information / 2022年10月 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥541,680 (USD3,660) | ▷ お問い合わせ |
| Corporate User | ￥1,083,360 (USD7,320) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 世界経済が回復するにつれて、2021年の第二世代セファロスポリンの成長は前年から大幅に変化します。LP Information社（米国）の最新の調査によると、世界の第二世代セファロスポリン市場規模は、2021年の000ドルから2022年には000ドルに達し、2021年～2022年間に000%の成長が予想されます。2028年には世界の第二世代セファロスポリン市場規模が000ドルまで成長し、調査期間中に000%の年平均成長率を記録すると予想されます。 米国の第二世代セファロスポリン市場は2021年に000ドルの市場規模が見込まれ、調査期間中は約000%の年平均成長率で成長すると予測されます。中国は世界の第二世代セファロスポリン市場の000%のシェアを占め、2028年までに000ドルに達すると展望されます。欧州の第二世代セファロスポリンの状況については、ドイツが2028年までに000ドルに達し、調査期間にわたって年平均成長率が000%になると予測されます。アジア地域では、日本と韓国の成長率が、今後5年間でそれぞれ000%と000%になると展望されます。 世界の主要な第二世代セファロスポリンプレーヤーとして、Apotex、 Esseti Farmaceutici、 GSK、 Lilly、 Medochemie、 Northeast Pharmaceutical、 NCPC、 Nanchang Lijian Pharmaceutical、 Sichuan Pharmaceutical、 Shandong Runze Pharmaceutical、 Shandong Luoxin Pharmaceutical Group、 Guangdong Bozhou Pharmaceutical、 Guangdong Jincheng Jinsu Pharmaceutical、 Guangzhou Baiyunshan Tianxin Pharmaceutical、 Guangxi Keluなどをカバーしています。売上の面では、世界のトップ2社が2021年に約000%市場シェアを占めています。 当レポートでは、製品タイプ、用途（アプリケーション）、主要メーカー、主要地域および国ごとの第二世代セファロスポリン市場の包括的な概要、市場シェア、および成長機会を掲載します。 タイプ別のセグメンテーション：2017年～2022年までの内訳データと2028年まで予測データ セフォティアム、セフロキシム 用途（アプリケーション）別のセグメンテーション：2017年～2022年までの内訳データと2028年まで予測データ 呼吸器感染症、耳鼻咽喉科感染症、尿路感染症、皮膚＆軟部組織感染症、骨＆関節感染症、淋病、その他 当レポートは次の地域と国の市場規模データを掲載します。 南北アメリカ（米国、カナダ、メキシコ、ブラジル） アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア） 欧州（ドイツ、フランス、イギリス、イタリア、ロシア） 中東/アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国） ********* 目次 ********* レポートの範囲 ・市場の紹介 ・分析対象期間 ・調査の目的 ・調査手法 ・調査プロセスおよびデータソース ・経済指標 ・通貨 エグゼクティブサマリー ・世界市場の概要：第二世代セファロスポリンの年間販売量2017-2028、地域別現状・将来分析 ・第二世代セファロスポリンのタイプ別セグメント：セフォティアム、セフロキシム ・第二世代セファロスポリンのタイプ別販売量：2017-2022年の販売量、売上、市場シェア、販売価格 ・第二世代セファロスポリンの用途別セグメント：呼吸器感染症、耳鼻咽喉科感染症、尿路感染症、皮膚＆軟部組織感染症、骨＆関節感染症、淋病、その他 ・第二世代セファロスポリンの用途別販売量：2017-2022年の販売量、売上、市場シェア、販売価格 企業別世界の第二世代セファロスポリン市場 ・企業別のグローバル第二世代セファロスポリン市場データ：2020-2022年の年間販売量、市場シェア ・企業別の第二世代セファロスポリンの年間売上：2020-2022年の売上、市場シェア ・企業別の第二世代セファロスポリン販売価格 ・主要企業の第二世代セファロスポリン生産地域、販売地域、製品タイプ ・市場集中度分析 ・新製品および潜在的な参加者 ・合併と買収、拡大 第二世代セファロスポリンの地域別レビュー ・地域別の第二世代セファロスポリン市場規模2017-2022：年間販売量、売上 ・主要国別の第二世代セファロスポリン市場規模2017-2022：年間販売量、売上 ・南北アメリカの第二世代セファロスポリン販売の成長 ・アジア太平洋の第二世代セファロスポリン販売の成長 ・欧州の第二世代セファロスポリン販売の成長 ・中東・アフリカの第二世代セファロスポリン販売の成長 南北アメリカ市場 ・南北アメリカの国別の第二世代セファロスポリン販売量、売上（2017-2022） ・南北アメリカの第二世代セファロスポリンの種類別販売量 ・南北アメリカの第二世代セファロスポリンの用途別販売量 ・米国の第二世代セファロスポリン市場 ・カナダの第二世代セファロスポリン市場 ・メキシコの第二世代セファロスポリン市場 ・ブラジルの第二世代セファロスポリン市場 アジア太平洋市場 ・アジア太平洋の国別の第二世代セファロスポリン販売量、売上（2017-2022） ・アジア太平洋の第二世代セファロスポリンの種類別販売量 ・アジア太平洋の第二世代セファロスポリンの用途別販売量 ・中国市場の第二世代セファロスポリン市場 ・日本市場の第二世代セファロスポリン市場 ・韓国市場の第二世代セファロスポリン市場 ・東南アジアの第二世代セファロスポリン市場 ・インドの第二世代セファロスポリン市場 ・オーストラリアの第二世代セファロスポリン市場 ・台湾の第二世代セファロスポリン市場 欧州市場 ・欧州の国別の第二世代セファロスポリン販売量、売上（2017-2022） ・欧州の第二世代セファロスポリンの種類別販売量 ・欧州の第二世代セファロスポリンの用途別販売量 ・ドイツの第二世代セファロスポリン市場 ・フランスの第二世代セファロスポリン市場 ・イギリスの第二世代セファロスポリン市場 ・イタリアの第二世代セファロスポリン市場 ・ロシアの第二世代セファロスポリン市場 中東・アフリカ市場 ・中東・アフリカの国別の第二世代セファロスポリン販売量、売上（2017-2022） ・中東・アフリカの第二世代セファロスポリンの種類別販売量 ・中東・アフリカの第二世代セファロスポリンの用途別販売量 ・エジプトの第二世代セファロスポリン市場 ・南アフリカの第二世代セファロスポリン市場 ・イスラエルの第二世代セファロスポリン市場 ・トルコの第二世代セファロスポリン市場 ・GCC諸国の第二世代セファロスポリン市場 市場の成長要因、課題、動向 ・市場の成長要因および成長機会分析 ・市場の課題およびリスク ・市場動向 製造コスト構造分析 ・原材料とサプライヤー ・第二世代セファロスポリンの製造コスト構造分析 ・第二世代セファロスポリンの製造プロセス分析 ・第二世代セファロスポリンの産業チェーン構造 マーケティング、販売業者および顧客 ・販売チャンネル：直接販売チャンネル、間接販売チャンネル ・第二世代セファロスポリンの主要なグローバル販売業者 ・第二世代セファロスポリンの主要なグローバル顧客 地域別の第二世代セファロスポリン市場予測レビュー ・地域別の第二世代セファロスポリン市場規模予測（2023-2028） ・南北アメリカの国別予測 ・アジア太平洋の国別予測 ・欧州の国別予測 ・第二世代セファロスポリンのタイプ別市場規模予測 ・第二世代セファロスポリンの用途別市場規模予測 主要企業分析 Apotex、 Esseti Farmaceutici、 GSK、 Lilly、 Medochemie、 Northeast Pharmaceutical、 NCPC、 Nanchang Lijian Pharmaceutical、 Sichuan Pharmaceutical、 Shandong Runze Pharmaceutical、 Shandong Luoxin Pharmaceutical Group、 Guangdong Bozhou Pharmaceutical、 Guangdong Jincheng Jinsu Pharmaceutical、 Guangzhou Baiyunshan Tianxin Pharmaceutical、 Guangxi Kelu ・企業情報 ・第二世代セファロスポリン製品 ・第二世代セファロスポリン販売量、売上、価格、粗利益（2020-2022） ・主要ビジネス概要 ・最新動向 調査結果および結論 |
As the global economy mends, the 2021 growth of Second Generation Cephalosporins will have significant change from previous year. According to our (LP Information) latest study, the global Second Generation Cephalosporins market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Second Generation Cephalosporins market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Second Generation Cephalosporins market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Second Generation Cephalosporins market, reaching US$ million by the year 2028. As for the Europe Second Generation Cephalosporins landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Second Generation Cephalosporins players cover Apotex, Esseti Farmaceutici, GSK, and Lilly, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Second Generation Cephalosporins market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Cefotiam
Cefuroxime
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Respiratory Tract Infection
Otolaryngological Infection
Urinary Tract Infection
Skin and Soft Tissue Infections
Bone and Joint Infections
Gonorrhea
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Apotex
Esseti Farmaceutici
GSK
Lilly
Medochemie
Northeast Pharmaceutical
NCPC
Nanchang Lijian Pharmaceutical
Sichuan Pharmaceutical
Shandong Runze Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Guangdong Bozhou Pharmaceutical
Guangdong Jincheng Jinsu Pharmaceutical
Guangzhou Baiyunshan Tianxin Pharmaceutical
Guangxi Kelun Pharmaceutical
Yuekang Pharmaceutical Group
Shantou Jinshi Injection
Zhejiang Yatai Pharmaceutical
Shenzhen Xinlitai Pharmaceutical
Shenzhen Huarun Jiuxin Pharmaceutical
Zhuhai Union Pharmaceutical
Ruiyang Pharmaceutical
Fujian Fukang Pharmaceutical
Suzhou Erye Pharmaceutical
Furen Pharmaceutical Group
Chongqing Kerui Pharmaceutical Group
Shanxi Xidunsi Pharmaceutical
Qilu Pharmaceutical
Shandong Zibo Xinda Pharmaceutical
Guangzhou Nanxin Pharmaceutical
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Second Generation Cephalosporins Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Second Generation Cephalosporins by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Second Generation Cephalosporins by Country/Region, 2017, 2022 & 2028
2.2 Second Generation Cephalosporins Segment by Type
2.2.1 Cefotiam
2.2.2 Cefuroxime
2.3 Second Generation Cephalosporins Sales by Type
2.3.1 Global Second Generation Cephalosporins Sales Market Share by Type (2017-2022)
2.3.2 Global Second Generation Cephalosporins Revenue and Market Share by Type (2017-2022)
2.3.3 Global Second Generation Cephalosporins Sale Price by Type (2017-2022)
2.4 Second Generation Cephalosporins Segment by Application
2.4.1 Respiratory Tract Infection
2.4.2 Otolaryngological Infection
2.4.3 Urinary Tract Infection
2.4.4 Skin and Soft Tissue Infections
2.4.5 Bone and Joint Infections
2.4.6 Gonorrhea
2.4.7 Other
2.5 Second Generation Cephalosporins Sales by Application
2.5.1 Global Second Generation Cephalosporins Sale Market Share by Application (2017-2022)
2.5.2 Global Second Generation Cephalosporins Revenue and Market Share by Application (2017-2022)
2.5.3 Global Second Generation Cephalosporins Sale Price by Application (2017-2022)
3 Global Second Generation Cephalosporins by Company
3.1 Global Second Generation Cephalosporins Breakdown Data by Company
3.1.1 Global Second Generation Cephalosporins Annual Sales by Company (2020-2022)
3.1.2 Global Second Generation Cephalosporins Sales Market Share by Company (2020-2022)
3.2 Global Second Generation Cephalosporins Annual Revenue by Company (2020-2022)
3.2.1 Global Second Generation Cephalosporins Revenue by Company (2020-2022)
3.2.2 Global Second Generation Cephalosporins Revenue Market Share by Company (2020-2022)
3.3 Global Second Generation Cephalosporins Sale Price by Company
3.4 Key Manufacturers Second Generation Cephalosporins Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Second Generation Cephalosporins Product Location Distribution
3.4.2 Players Second Generation Cephalosporins Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Second Generation Cephalosporins by Geographic Region
4.1 World Historic Second Generation Cephalosporins Market Size by Geographic Region (2017-2022)
4.1.1 Global Second Generation Cephalosporins Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Second Generation Cephalosporins Annual Revenue by Geographic Region
4.2 World Historic Second Generation Cephalosporins Market Size by Country/Region (2017-2022)
4.2.1 Global Second Generation Cephalosporins Annual Sales by Country/Region (2017-2022)
4.2.2 Global Second Generation Cephalosporins Annual Revenue by Country/Region
4.3 Americas Second Generation Cephalosporins Sales Growth
4.4 APAC Second Generation Cephalosporins Sales Growth
4.5 Europe Second Generation Cephalosporins Sales Growth
4.6 Middle East & Africa Second Generation Cephalosporins Sales Growth
5 Americas
5.1 Americas Second Generation Cephalosporins Sales by Country
5.1.1 Americas Second Generation Cephalosporins Sales by Country (2017-2022)
5.1.2 Americas Second Generation Cephalosporins Revenue by Country (2017-2022)
5.2 Americas Second Generation Cephalosporins Sales by Type
5.3 Americas Second Generation Cephalosporins Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Second Generation Cephalosporins Sales by Region
6.1.1 APAC Second Generation Cephalosporins Sales by Region (2017-2022)
6.1.2 APAC Second Generation Cephalosporins Revenue by Region (2017-2022)
6.2 APAC Second Generation Cephalosporins Sales by Type
6.3 APAC Second Generation Cephalosporins Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Second Generation Cephalosporins by Country
7.1.1 Europe Second Generation Cephalosporins Sales by Country (2017-2022)
7.1.2 Europe Second Generation Cephalosporins Revenue by Country (2017-2022)
7.2 Europe Second Generation Cephalosporins Sales by Type
7.3 Europe Second Generation Cephalosporins Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Second Generation Cephalosporins by Country
8.1.1 Middle East & Africa Second Generation Cephalosporins Sales by Country (2017-2022)
8.1.2 Middle East & Africa Second Generation Cephalosporins Revenue by Country (2017-2022)
8.2 Middle East & Africa Second Generation Cephalosporins Sales by Type
8.3 Middle East & Africa Second Generation Cephalosporins Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Second Generation Cephalosporins
10.3 Manufacturing Process Analysis of Second Generation Cephalosporins
10.4 Industry Chain Structure of Second Generation Cephalosporins
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Second Generation Cephalosporins Distributors
11.3 Second Generation Cephalosporins Customer
12 World Forecast Review for Second Generation Cephalosporins by Geographic Region
12.1 Global Second Generation Cephalosporins Market Size Forecast by Region
12.1.1 Global Second Generation Cephalosporins Forecast by Region (2023-2028)
12.1.2 Global Second Generation Cephalosporins Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Second Generation Cephalosporins Forecast by Type
12.7 Global Second Generation Cephalosporins Forecast by Application
13 Key Players Analysis
13.1 Apotex
13.1.1 Apotex Company Information
13.1.2 Apotex Second Generation Cephalosporins Product Offered
13.1.3 Apotex Second Generation Cephalosporins Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Apotex Main Business Overview
13.1.5 Apotex Latest Developments
13.2 Esseti Farmaceutici
13.2.1 Esseti Farmaceutici Company Information
13.2.2 Esseti Farmaceutici Second Generation Cephalosporins Product Offered
13.2.3 Esseti Farmaceutici Second Generation Cephalosporins Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Esseti Farmaceutici Main Business Overview
13.2.5 Esseti Farmaceutici Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Second Generation Cephalosporins Product Offered
13.3.3 GSK Second Generation Cephalosporins Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Lilly
13.4.1 Lilly Company Information
13.4.2 Lilly Second Generation Cephalosporins Product Offered
13.4.3 Lilly Second Generation Cephalosporins Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Lilly Main Business Overview
13.4.5 Lilly Latest Developments
13.5 Medochemie
13.5.1 Medochemie Company Information
13.5.2 Medochemie Second Generation Cephalosporins Product Offered
13.5.3 Medochemie Second Generation Cephalosporins Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Medochemie Main Business Overview
13.5.5 Medochemie Latest Developments
13.6 Northeast Pharmaceutical
13.6.1 Northeast Pharmaceutical Company Information
13.6.2 Northeast Pharmaceutical Second Generation Cephalosporins Product Offered
13.6.3 Northeast Pharmaceutical Second Generation Cephalosporins Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Northeast Pharmaceutical Main Business Overview
13.6.5 Northeast Pharmaceutical Latest Developments
13.7 NCPC
13.7.1 NCPC Company Information
13.7.2 NCPC Second Generation Cephalosporins Product Offered
13.7.3 NCPC Second Generation Cephalosporins Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 NCPC Main Business Overview
13.7.5 NCPC Latest Developments
13.8 Nanchang Lijian Pharmaceutical
13.8.1 Nanchang Lijian Pharmaceutical Company Information
13.8.2 Nanchang Lijian Pharmaceutical Second Generation Cephalosporins Product Offered
13.8.3 Nanchang Lijian Pharmaceutical Second Generation Cephalosporins Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Nanchang Lijian Pharmaceutical Main Business Overview
13.8.5 Nanchang Lijian Pharmaceutical Latest Developments
13.9 Sichuan Pharmaceutical
13.9.1 Sichuan Pharmaceutical Company Information
13.9.2 Sichuan Pharmaceutical Second Generation Cephalosporins Product Offered
13.9.3 Sichuan Pharmaceutical Second Generation Cephalosporins Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Sichuan Pharmaceutical Main Business Overview
13.9.5 Sichuan Pharmaceutical Latest Developments
13.10 Shandong Runze Pharmaceutical
13.10.1 Shandong Runze Pharmaceutical Company Information
13.10.2 Shandong Runze Pharmaceutical Second Generation Cephalosporins Product Offered
13.10.3 Shandong Runze Pharmaceutical Second Generation Cephalosporins Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Shandong Runze Pharmaceutical Main Business Overview
13.10.5 Shandong Runze Pharmaceutical Latest Developments
13.11 Shandong Luoxin Pharmaceutical Group
13.11.1 Shandong Luoxin Pharmaceutical Group Company Information
13.11.2 Shandong Luoxin Pharmaceutical Group Second Generation Cephalosporins Product Offered
13.11.3 Shandong Luoxin Pharmaceutical Group Second Generation Cephalosporins Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Shandong Luoxin Pharmaceutical Group Main Business Overview
13.11.5 Shandong Luoxin Pharmaceutical Group Latest Developments
13.12 Guangdong Bozhou Pharmaceutical
13.12.1 Guangdong Bozhou Pharmaceutical Company Information
13.12.2 Guangdong Bozhou Pharmaceutical Second Generation Cephalosporins Product Offered
13.12.3 Guangdong Bozhou Pharmaceutical Second Generation Cephalosporins Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Guangdong Bozhou Pharmaceutical Main Business Overview
13.12.5 Guangdong Bozhou Pharmaceutical Latest Developments
13.13 Guangdong Jincheng Jinsu Pharmaceutical
13.13.1 Guangdong Jincheng Jinsu Pharmaceutical Company Information
13.13.2 Guangdong Jincheng Jinsu Pharmaceutical Second Generation Cephalosporins Product Offered
13.13.3 Guangdong Jincheng Jinsu Pharmaceutical Second Generation Cephalosporins Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Guangdong Jincheng Jinsu Pharmaceutical Main Business Overview
13.13.5 Guangdong Jincheng Jinsu Pharmaceutical Latest Developments
13.14 Guangzhou Baiyunshan Tianxin Pharmaceutical
13.14.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Company Information
13.14.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Second Generation Cephalosporins Product Offered
13.14.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Second Generation Cephalosporins Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Main Business Overview
13.14.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Latest Developments
13.15 Guangxi Kelun Pharmaceutical
13.15.1 Guangxi Kelun Pharmaceutical Company Information
13.15.2 Guangxi Kelun Pharmaceutical Second Generation Cephalosporins Product Offered
13.15.3 Guangxi Kelun Pharmaceutical Second Generation Cephalosporins Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Guangxi Kelun Pharmaceutical Main Business Overview
13.15.5 Guangxi Kelun Pharmaceutical Latest Developments
13.16 Yuekang Pharmaceutical Group
13.16.1 Yuekang Pharmaceutical Group Company Information
13.16.2 Yuekang Pharmaceutical Group Second Generation Cephalosporins Product Offered
13.16.3 Yuekang Pharmaceutical Group Second Generation Cephalosporins Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Yuekang Pharmaceutical Group Main Business Overview
13.16.5 Yuekang Pharmaceutical Group Latest Developments
13.17 Shantou Jinshi Injection
13.17.1 Shantou Jinshi Injection Company Information
13.17.2 Shantou Jinshi Injection Second Generation Cephalosporins Product Offered
13.17.3 Shantou Jinshi Injection Second Generation Cephalosporins Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Shantou Jinshi Injection Main Business Overview
13.17.5 Shantou Jinshi Injection Latest Developments
13.18 Zhejiang Yatai Pharmaceutical
13.18.1 Zhejiang Yatai Pharmaceutical Company Information
13.18.2 Zhejiang Yatai Pharmaceutical Second Generation Cephalosporins Product Offered
13.18.3 Zhejiang Yatai Pharmaceutical Second Generation Cephalosporins Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Zhejiang Yatai Pharmaceutical Main Business Overview
13.18.5 Zhejiang Yatai Pharmaceutical Latest Developments
13.19 Shenzhen Xinlitai Pharmaceutical
13.19.1 Shenzhen Xinlitai Pharmaceutical Company Information
13.19.2 Shenzhen Xinlitai Pharmaceutical Second Generation Cephalosporins Product Offered
13.19.3 Shenzhen Xinlitai Pharmaceutical Second Generation Cephalosporins Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Shenzhen Xinlitai Pharmaceutical Main Business Overview
13.19.5 Shenzhen Xinlitai Pharmaceutical Latest Developments
13.20 Shenzhen Huarun Jiuxin Pharmaceutical
13.20.1 Shenzhen Huarun Jiuxin Pharmaceutical Company Information
13.20.2 Shenzhen Huarun Jiuxin Pharmaceutical Second Generation Cephalosporins Product Offered
13.20.3 Shenzhen Huarun Jiuxin Pharmaceutical Second Generation Cephalosporins Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Shenzhen Huarun Jiuxin Pharmaceutical Main Business Overview
13.20.5 Shenzhen Huarun Jiuxin Pharmaceutical Latest Developments
13.21 Zhuhai Union Pharmaceutical
13.21.1 Zhuhai Union Pharmaceutical Company Information
13.21.2 Zhuhai Union Pharmaceutical Second Generation Cephalosporins Product Offered
13.21.3 Zhuhai Union Pharmaceutical Second Generation Cephalosporins Sales, Revenue, Price and Gross Margin (2020-2022)
13.21.4 Zhuhai Union Pharmaceutical Main Business Overview
13.21.5 Zhuhai Union Pharmaceutical Latest Developments
13.22 Ruiyang Pharmaceutical
13.22.1 Ruiyang Pharmaceutical Company Information
13.22.2 Ruiyang Pharmaceutical Second Generation Cephalosporins Product Offered
13.22.3 Ruiyang Pharmaceutical Second Generation Cephalosporins Sales, Revenue, Price and Gross Margin (2020-2022)
13.22.4 Ruiyang Pharmaceutical Main Business Overview
13.22.5 Ruiyang Pharmaceutical Latest Developments
13.23 Fujian Fukang Pharmaceutical
13.23.1 Fujian Fukang Pharmaceutical Company Information
13.23.2 Fujian Fukang Pharmaceutical Second Generation Cephalosporins Product Offered
13.23.3 Fujian Fukang Pharmaceutical Second Generation Cephalosporins Sales, Revenue, Price and Gross Margin (2020-2022)
13.23.4 Fujian Fukang Pharmaceutical Main Business Overview
13.23.5 Fujian Fukang Pharmaceutical Latest Developments
13.24 Suzhou Erye Pharmaceutical
13.24.1 Suzhou Erye Pharmaceutical Company Information
13.24.2 Suzhou Erye Pharmaceutical Second Generation Cephalosporins Product Offered
13.24.3 Suzhou Erye Pharmaceutical Second Generation Cephalosporins Sales, Revenue, Price and Gross Margin (2020-2022)
13.24.4 Suzhou Erye Pharmaceutical Main Business Overview
13.24.5 Suzhou Erye Pharmaceutical Latest Developments
13.25 Furen Pharmaceutical Group
13.25.1 Furen Pharmaceutical Group Company Information
13.25.2 Furen Pharmaceutical Group Second Generation Cephalosporins Product Offered
13.25.3 Furen Pharmaceutical Group Second Generation Cephalosporins Sales, Revenue, Price and Gross Margin (2020-2022)
13.25.4 Furen Pharmaceutical Group Main Business Overview
13.25.5 Furen Pharmaceutical Group Latest Developments
13.26 Chongqing Kerui Pharmaceutical Group
13.26.1 Chongqing Kerui Pharmaceutical Group Company Information
13.26.2 Chongqing Kerui Pharmaceutical Group Second Generation Cephalosporins Product Offered
13.26.3 Chongqing Kerui Pharmaceutical Group Second Generation Cephalosporins Sales, Revenue, Price and Gross Margin (2020-2022)
13.26.4 Chongqing Kerui Pharmaceutical Group Main Business Overview
13.26.5 Chongqing Kerui Pharmaceutical Group Latest Developments
13.27 Shanxi Xidunsi Pharmaceutical
13.27.1 Shanxi Xidunsi Pharmaceutical Company Information
13.27.2 Shanxi Xidunsi Pharmaceutical Second Generation Cephalosporins Product Offered
13.27.3 Shanxi Xidunsi Pharmaceutical Second Generation Cephalosporins Sales, Revenue, Price and Gross Margin (2020-2022)
13.27.4 Shanxi Xidunsi Pharmaceutical Main Business Overview
13.27.5 Shanxi Xidunsi Pharmaceutical Latest Developments
13.28 Qilu Pharmaceutical
13.28.1 Qilu Pharmaceutical Company Information
13.28.2 Qilu Pharmaceutical Second Generation Cephalosporins Product Offered
13.28.3 Qilu Pharmaceutical Second Generation Cephalosporins Sales, Revenue, Price and Gross Margin (2020-2022)
13.28.4 Qilu Pharmaceutical Main Business Overview
13.28.5 Qilu Pharmaceutical Latest Developments
13.29 Shandong Zibo Xinda Pharmaceutical
13.29.1 Shandong Zibo Xinda Pharmaceutical Company Information
13.29.2 Shandong Zibo Xinda Pharmaceutical Second Generation Cephalosporins Product Offered
13.29.3 Shandong Zibo Xinda Pharmaceutical Second Generation Cephalosporins Sales, Revenue, Price and Gross Margin (2020-2022)
13.29.4 Shandong Zibo Xinda Pharmaceutical Main Business Overview
13.29.5 Shandong Zibo Xinda Pharmaceutical Latest Developments
13.30 Guangzhou Nanxin Pharmaceutical
13.30.1 Guangzhou Nanxin Pharmaceutical Company Information
13.30.2 Guangzhou Nanxin Pharmaceutical Second Generation Cephalosporins Product Offered
13.30.3 Guangzhou Nanxin Pharmaceutical Second Generation Cephalosporins Sales, Revenue, Price and Gross Margin (2020-2022)
13.30.4 Guangzhou Nanxin Pharmaceutical Main Business Overview
13.30.5 Guangzhou Nanxin Pharmaceutical Latest Developments
14 Research Findings and Conclusion